Deals
Palatine exits Veincentre in SBO to CBPE
Sale of varicose vein treatment clinic chain is the second exit from 2016-vintage impact fund
The Bolt-Ons Digest – 17 October 2022
Unquote’s selection of the latest add-ons with Equistone's Ligentia, Bridgepoint's Infinigate, Ambienta’s Namirial and more
Advent to merge Caldic with Wilbur-Ellis’ Connell
Focused on nutrition, pharma, and industrial formulations, group aims to expand in APAC, LatAm
Vitruvian reignites exit plans for aviation data firm OAG
Sponsor expected to hire advisors in the next months for sale of asset held since 2017
Oakley Capital to partially exit Wishcard to IK, EMZ
Sale of German gift cards group sees founding management regaining majority position
Siparex exits Le Temps des Cerises in management-backed SBO
Trocadero Capital, Turenne and Smalt Capital join apparel brand as minority investors
Private equity buyouts hit lowest point since COVID
Amid macro uncertainty, sponsors see EUR 44.6bn deployed across 211 buyouts, in the lowest mark since Q3 2020
Volpi kicks off fund III deployment with Xalient buyout
Tech GP says specialist focus gave edge in competitive sale; will grow cybersecurity group with M&A
Aurelius exits Briar Chemicals to trade for EUR 83m
Fine chemicals group to become part of Safex Chemicals India's European business
Graphite weighs Compass Fostering exit advised by Harris Williams
Sale unlikely to launch soon given downturn in children fostering services space
Graphite Capital buys Digital Space from Horizon Capital
IT services business sold to UK-based mid-market sponsor in an SBO
YFM reaps 4x-plus return in Springboard sale to US trade
Acquisition of footfall data analytics group will expand MRI Software’s retail solutions offering
Palatine exits Acora at 3x-plus money in sale to LDC
GP sells minority stake after less than three years invested in the IT managed services provider
Silverfleet to reap 3.1x money from TrustQuay sale to Hg
Exit of UK-based software provider set to generate 40%-plus IRR; Baird advised on auction
Novalpina fund exits Laboratoire XO to Stanley Capital
French drug maker is the first divestment from liquidated fund Novalpina I, now managed by Berkeley Research Group
Assietta Private Equity preps Naturalia Tantum exit
Equita and Houlihan Lokey hired for upcoming sale of Italian natural cosmetics group
Green Arrow sells Somacis Graphic in SBO to Chequers
Sale of Italian printed circuit boards marks second exit of Milan-based GP’s Fund 3
Corsair-backed IDNow halts sale plans amid valuation gap
Informal talks held with potential bidders in the summer; EUR 60m debt line arranged last month
DPE raises EUR 708m continuation fund for two IT consultancies
German GP’s new vehicle backed by AlpInvest, HarbourVest Partners and Pantheon Ventures
HIG explores sale of Germany-based HCS Group
Rothschild retained to test market appetite for hydrocarbon and specialty solutions supplier
MCF Corporate Finance buys Cubus in debt advisory expansion
Deal with Frankfurt-based firm follows demand for combined M&A and financing services
Stirling Square buys Eurofins Digital Testing for EUR 220m
Mid-market GP is deploying 2020 Fun IV in primary carve-out from French laboratories company
GENUI explores Labor Team W exit just a year after labs group buyout
Rothschild hired to assess options after Swiss asset attracted inbound interest from trade
Vaaka Partners preps Unisport exit, Deloitte mandated
Nordic sports facility surfaces and equipment company could attract large European peers